Unknown

Dataset Information

0

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.


ABSTRACT: Protein kinases of the CK1 family can be involved in numerous physiological and pathophysiological processes. Dysregulated expression and/or activity as well as mutation of CK1 isoforms have previously been linked to tumorigenesis. Among all neoplastic diseases, colon and rectal cancer (CRC) represent the fourth leading cause of cancer related deaths. Since mutations in CK1? previously found in CRC patients exhibited increased oncogenic features, inhibition of CK1? is supposed to have promising therapeutic potential for tumors, which present overexpression or mutations of this CK1 isoform. Therefore, it is important to develop new small molecule inhibitors exhibiting higher affinity toward CK1? mutants. In the present study, we first characterized the kinetic properties of CK1? mutants, which were detected in different tumor entities. Subsequently, we characterized the ability of several newly developed IWP-based inhibitors to inhibit wild type and CK1? mutants and we furthermore analyzed their effects on growth inhibition of various cultured colon cancer cell lines. Our results indicate, that these compounds represent a promising base for the development of novel CRC therapy concepts.

SUBMITTER: Liu C 

PROVIDER: S-EPMC6941124 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.

Liu Congxing C   Witt Lydia L   Ianes Chiara C   Bischof Joachim J   Bammert Marie-Thérèse MT   Baier Joana J   Kirschner Stefan S   Henne-Bruns Doris D   Xu Pengfei P   Kornmann Marko M   Peifer Christian C   Knippschild Uwe U  

International journal of molecular sciences 20191207 24


Protein kinases of the CK1 family can be involved in numerous physiological and pathophysiological processes. Dysregulated expression and/or activity as well as mutation of CK1 isoforms have previously been linked to tumorigenesis. Among all neoplastic diseases, colon and rectal cancer (CRC) represent the fourth leading cause of cancer related deaths. Since mutations in CK1δ previously found in CRC patients exhibited increased oncogenic features, inhibition of CK1δ is supposed to have promising  ...[more]

Similar Datasets

| S-EPMC6426469 | biostudies-literature
| S-EPMC4025826 | biostudies-other
2024-02-28 | GSE258991 | GEO
| S-EPMC10822850 | biostudies-literature
| S-EPMC10823279 | biostudies-literature
| S-EPMC2262898 | biostudies-literature
| S-EPMC5576104 | biostudies-literature
| S-EPMC10372842 | biostudies-literature
| S-EPMC4087096 | biostudies-literature
| S-EPMC5507442 | biostudies-literature